PTX3 is expressed and released by different cell types at the site of inflammation, e.g., innate immune cells, stromal cells, as well as cancer cells, in contrast with CRP or SAP, which are primarily produced within the liver due to IL-6 mediated inflammation. Here, IL6 is linked to cancer.